Psychedelics at 6th Annual Conference on Psychedelics and Psychedelic Medicine

08:35–08:55 · Lecture · Module 1: Introduction and Keynote

Psychedelic Pharmacology for Clinicians

Franklin King

Clinician-oriented overview of the pharmacology of psychedelic compounds.

Neuroscience & Mechanisms

08:55–09:45 · Keynote · Module 1: Introduction and Keynote

Keynote : Psychedelic-Assisted Therapy: Evidence, Experience, and Ongoing Questions

Stephen Ross

Keynote reviewing the evidence base, clinical experience and unresolved questions in psychedelic-assisted therapy.

Psychotherapy

09:45–10:15 · Panel · Module 1: Introduction and Keynote

Keynote Panel Discussion

Franklin King · Stephen Ross

Moderated discussion following the keynote address.

10:30–11:00 · Lecture · Module 2: Neurobiology & Brain States

Cognitive Networks and the Neuroscience of Depression Under Psychedelics

Sharmin Ghaznavi

Examines cognitive network changes underlying depression and how psychedelics influence them.

Depression · Neuroscience & Mechanisms

11:00–11:30 · Lecture · Module 2: Neurobiology & Brain States

Plant Medicines and the Psychedelome

Stephen Haggarty

Discusses plant-derived medicines and the molecular landscape of psychedelic compounds.

Neuroscience & Mechanisms

12:00–12:30 · Panel · Module 2: Neurobiology & Brain States

Panel Discussion

Jerrold F. Rosenbaum · Sharmin Ghaznavi · Stephen Haggarty · Matthew Sacchet

Moderated discussion of the neurobiology and brain-state topics presented in Module 2.

Neuroscience & Mechanisms

14:30–15:00 · Lecture · Module 3: Therapeutic Models

Psychoanalysis and Psychotherapy in Psychedelic Treatment

Roxanne Sholevar

Considers the role of psychoanalytic and psychotherapeutic frameworks in psychedelic treatment.

Psychotherapy

15:00–15:30 · Lecture · Module 3: Therapeutic Models

Psychedelics in Cancer Care: Update on State of Current Research

Yvan Beaussant

Updates current research on psychedelic treatments for patients with cancer.

Medical Comorbidity & C-L Psychiatry

08:35–09:05 · Lecture · Module 4: Clinical Expansion, Psychosomatics, and Translational Imaging

Implementation Challenges in Psychedelic Care

Peter Hendricks

Examines practical obstacles to delivering psychedelic care in clinical settings.

Practice, Policy & Workforce

09:05–09:35 · Lecture · Module 4: Clinical Expansion, Psychosomatics, and Translational Imaging

Psychedelics & Borderline Personality Disorder: Too Risky, or Potential Treatment

Jenna Traynor

Weighs the risks and therapeutic potential of psychedelics for people with borderline personality disorder.

Personality Disorders

09:35–10:05 · Lecture · Module 4: Clinical Expansion, Psychosomatics, and Translational Imaging

MDMA-Assisted Therapy and Simultaneous Patient-Therapist Neuroimaging in Pain

Vitaly Napadow

Covers MDMA-assisted therapy for pain and neuroimaging of patient and therapist together.

Neuroscience & Mechanisms · Medical Comorbidity & C-L Psychiatry

10:05–10:35 · Panel · Module 4: Clinical Expansion, Psychosomatics, and Translational Imaging

Panel Discussion

Franklin King · Peter Hendricks · Jenna Traynor · Vitaly Napadow

Panel discussion on the Module 4 topics of clinical expansion and imaging.

10:50–11:20 · Lecture · Module 5: Culture & Naturalistic Risk

Psychedelic Churches and Sacred Use

Jeffrey Breau

Explores religious and sacred contexts of psychedelic use.

Diverse & Underserved Populations

11:20–11:50 · Lecture · Module 5: Culture & Naturalistic Risk

Population-Level Risks in Naturalistic Psychedelic Use

Grant Jones

Reviews population-level risks associated with naturalistic psychedelic use.

Drug Interactions & Safety

13:20–13:50 · Lecture · Module 6: Experience, Meaning, and Clinical Risk

Studying Psychedelics in Academic Medicine: Methodological and Conceptual Challenges

Franklin King

Discusses methodological and conceptual challenges in psychedelic research within academic medicine.

Drug Pipeline & Clinical Trials

13:50–14:20 · Lecture · Module 6: Experience, Meaning, and Clinical Risk

Music in Psychedelic Therapy Sessions

Lisa Summer

Looks at the role of music during psychedelic therapy sessions.

Psychotherapy

14:20–14:50 · Lecture · Module 6: Experience, Meaning, and Clinical Risk

Clinical Risks and Adverse Outcomes in Psychedelic Therapies

Kelley O’Donnell

Reviews clinical risks and adverse outcomes associated with psychedelic therapies.

Drug Interactions & Safety